Screener
Relay Therapeutics, Inc. RLAY Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
FAQ
- What is Relay Therapeutics, Inc.'s restricted cash?
- Relay Therapeutics, Inc. (RLAY) reported restricted cash of $1.34M in Q2 2026.
- How has Relay Therapeutics, Inc.'s restricted cash changed year-over-year?
- Relay Therapeutics, Inc.'s restricted cash decreased by 40.8% year-over-year, from $2.26M to $1.34M.
- What is the long-term trend for Relay Therapeutics, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s restricted cash has grown at a 8.8% compound annual growth rate (CAGR), from $878K to $1.34M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Relay Therapeutics, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude